Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1968 1
1975 2
1976 1
1977 1
1978 1
1981 1
1982 1
1985 1
1986 3
1987 3
1988 6
1989 6
1990 5
1991 6
1992 4
1995 3
1996 5
1997 2
1998 4
1999 5
2000 5
2001 3
2002 7
2003 5
2004 12
2005 6
2006 5
2007 7
2008 5
2009 6
2010 3
2011 2
2012 6
2013 4
2014 3
2015 13
2016 10
2017 8
2018 8
2019 7
2020 7
2021 1
2022 5
2023 8
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Results by year

Filters applied: . Clear all
Page 1
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.
Choon SE, van de Kerkhof P, Gudjonsson JE, de la Cruz C, Barker J, Morita A, Romiti R, Affandi AM, Asawanonda P, Burden AD, Gonzalez C, Marrakchi S, Mowla MR, Okubo Y, Oon HH, Terui T, Tsai TF, Callis-Duffin K, Fujita H, Jo SJ, Merola J, Mrowietz U, Puig L, Thaçi D, Velásquez M, Augustin M, El Sayed M, Navarini AA, Pink A, Prinz J, Turki H, Magalhães R, Capon F, Bachelez H; IPC Pustular Psoriasis Working Group. Choon SE, et al. JAMA Dermatol. 2024 Jul 1;160(7):758-768. doi: 10.1001/jamadermatol.2024.0915. JAMA Dermatol. 2024. PMID: 38691347
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.
Thaçi D, Vender R, de Rie MA, Conrad C, Pariser DM, Strober B, Vanvoorden V, Wang M, Madden C, de Cuyper D, Kimball AB. Thaçi D, et al. Among authors: de rie ma. Br J Dermatol. 2023 Jan 23;188(1):22-31. doi: 10.1093/bjd/ljac021. Br J Dermatol. 2023. PMID: 36689515 Clinical Trial.
Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study.
Iversen L, Eidsmo L, Austad J, de Rie M, Osmancevic A, Skov L, Talme T, Bachmann I, van de Kerkhof P, Stahle M, Banerjee R, Oliver J, Fasth AER, Frueh J. Iversen L, et al. Among authors: de rie m. J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1930-1939. doi: 10.1111/jdv.14979. Epub 2018 Jul 15. J Eur Acad Dermatol Venereol. 2018. PMID: 29633373 Clinical Trial.
Celebrating the 50th Anniversary of ESDR.
Peltonen S, Eming SA, Griffiths CEM, Széll M, Kelsell D, De Rie MA. Peltonen S, et al. Among authors: de rie ma. J Invest Dermatol. 2020 Sep;140(9S):S145-S146. doi: 10.1016/j.jid.2020.02.043. J Invest Dermatol. 2020. PMID: 32800154 Free article. No abstract available.
Cyclosporine immunotherapy.
de Rie MA, Bos JD. de Rie MA, et al. Clin Dermatol. 1997 Sep-Oct;15(5):811-21. doi: 10.1016/s0738-081x(97)00012-6. Clin Dermatol. 1997. PMID: 9313978 Review. No abstract available.
Respiratory intensive care.
Pontoppidan H, Wilson RS, Rie MA, Schneider RC. Pontoppidan H, et al. Among authors: rie ma. Anesthesiology. 1977 Aug;47(2):96-116. doi: 10.1097/00000542-197708000-00003. Anesthesiology. 1977. PMID: 327863 Free article. Review. No abstract available.
Overview of psoriasis.
de Rie MA, Goedkoop AY, Bos JD. de Rie MA, et al. Dermatol Ther. 2004;17(5):341-9. doi: 10.1111/j.1396-0296.2004.04037.x. Dermatol Ther. 2004. PMID: 15379769 Review.
Psoriasis: dysregulation of innate immunity.
Bos JD, de Rie MA, Teunissen MB, Piskin G. Bos JD, et al. Among authors: de rie ma. Br J Dermatol. 2005 Jun;152(6):1098-107. doi: 10.1111/j.1365-2133.2005.06645.x. Br J Dermatol. 2005. PMID: 15948970 Review.
194 results